Treatment of Genetic disorders-edited by Aishee Biswas

Genetic disorders arise from gene mutations or deletions, which may be inherited or caused by environmental factors. Stem cells, which are undifferentiated cells that can divide and regenerate themselves, have been extensively studied for their potential in regenerative medicine. Transit amplifying cells, which divide and give rise to multipotent progenitors, eventually develop into mature cell types. Adult stem cells found in bone marrow, such as hematopoietic stem cells, are already used to treat inherited and acquired blood and immune system diseases through bone marrow transplants. Patients with genetic mutations can donate their stem cells for examination and comparison with healthy controls. Dominantly inherited genetic diseases occur when a single copy of the mutated gene is present, while recessively inherited genetic diseases occur when both copies of the gene are mutated.

 

The doctors explained how adult stem cells are already being utilized to treat genetic diseases, specifically bone marrow transplants involving haematopoietic stem cells for immunological and blood disorders. Eligible donors are those with a known genetic mutation and diagnosis, and their stem cells can be used to analyze and compare genetic and metabolic pathways impacted by the disease.

 

In terms of stem cell usage for genetic diseases, doctors revealed that patients with acute leukemia, bone marrow aplasia, and congenital immunological deficiencies are treated with whole bone marrow intravenous infusions. The haematopoietic stem cell is a rare cell that serves as the foundation for all adult stem cell research, and its characteristics are critical to various treatments. With the advancement of techniques to separate and define adult stem cells, new cell-based therapies are being developed to treat a variety of hereditary diseases, beyond just blood disorders.

 

Infusing whole bone marrow via intravenous route is a treatment option for individuals suffering from congenital immunological defects, acute leukemia, and bone marrow aplasia. The haematopoietic stem cell, which is a rare cell type that serves as the foundation for all adult stem cell research, has unique properties that are essential for the success of various therapies. However, new cell-based therapies are being developed to treat a range of hereditary diseases, not just limited to blood disorders, with the aid of tools to separate and identify adult stem cells from other tissues.

 

According to the specialist, repairing tissues damaged by genetic mutations is the treatment for genetic disorders . To restore normal function, stem cells free of the mutation can be implanted from a tissue-matched donor, or genetically altered stem cells from the patient can be used for implantation. Stem cells, when obtained from sick individuals, have the ability to develop into the required cell type to restore normal tissue function following transplantation. They can also serve as cellular models for studying genetic and metabolic pathways in cells. However, when a gene affects multiple organs and requires transplantation at various locations, finding the therapeutic answer may not be straightforward. The most likely cellular-based transplantation therapies involve transplanting a single cell type into a single location.

 

To treat genetic diseases, damaged tissues caused by  genetic mutations can be repaired through cellular intervention . One possible method is the transplantation of stem cells that do not contain the mutation and have been obtained from a donor with a tissue match. Alternatively, the patient's own stem cells can be genetically altered prior to transplantation. Stem cells from individuals with genetic diseases have the potential to differentiate into the required cell type, restoring normal tissue function after transplantation. They can also be used as cellular models to investigate genetic and metabolic pathways. However, in cases where a gene affects multiple organs and requires transplantation in different locations, finding a therapeutic solution may be more challenging.

 

The biology of adult stem cells has the potential to aid in the study of hereditary diseases and gene-environment interactions by providing cell models for specific diseases. Stem cells are readily available and can be obtained from accurately diagnosed patients with a range of genetic components. According to the health expert, Adult stem cell-based cell models are utilized to identify the genes and metabolic processes involved in the cellular pathology of inherited diseases. Gene therapy and stem cell research have made significant progress. Since stem cells can self-renew, cell-based gene therapy may reduce or even eliminate the need for repeated injections of therapeutic cells. Gene therapy aims to treat diseases caused by damaged genes by replacing the function of a defective gene with a healthy one. This will facilitate the development of biomarkers and the identification of new targets for genetic-specific drug therapy.

 

In conclusion,  Exosomes play a crucial role in tumor biology by transmitting genetic information from cell to cell  and facilitating interactions between tumor cells and their surrounding microenvironment, such as fibroblasts, endothelial cells, adipocytes, and monocytes. Tumor cells have been shown to release exosomes that can influence neighboring cells by providing signaling molecules for cell stimulation, activation, proliferation, and differentiation. These exosomes contain mRNA, microRNA (miRNA), and proteins that can cause genetic and epigenetic changes in target cells. Moreover, by transferring bioactive molecules such as proteins, RNAs, and microRNAs, exosomes are believed to have a significant impact on tumor invasion and metastasis, inflammation, coagulation, as well as stem cell regeneration and expansion. This review article aims to discuss the importance of exosome-mediated cell-to-cell communication in tumor biology.